| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director
2 companies
Raab Michael is a President &CEO at ARDELYX, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $11.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2020 | FOLD Amicus Therapeutics, Inc. | Director | Sale+OE | 5,000 | $12.65 | $63,260.50 | -24.8% | |
| May 5, 2020 | ARDX Ardelyx, Inc. | President &CEO | Sell | 20,427 | $7.01 | $143,221.97 | -12.5% | |
| Apr 17, 2020 | ARDX Ardelyx, Inc. | President &CEO | Sell | 20,428 | $7.02 | $143,325.28 | -6.4% | |
| Mar 2, 2020 | ARDX Ardelyx, Inc. | President &CEO | Sale+OE | 31,551 | $7.01 | $221,145.03 | -9.0% | |
| Feb 5, 2020 | ARDX Ardelyx, Inc. | President &CEO | Sale+OE | 25,000 | $7.32 | $182,927.50 | -10.8% | |
| Jun 4, 2019 | ARDX Ardelyx, Inc. | President &CEO | Sell | 10,054 | $2.54 | $25,551.24 | -3.8% | |
| Jun 3, 2019 | FOLD Amicus Therapeutics, Inc. | Director | Sale+OE | 5,000 | $11.16 | $55,776.00 | -36.0% | |
| Jan 2, 2019 | ARDX Ardelyx, Inc. | President &CEO | Sell | 19,644 | $1.70 | $33,418.37 | -7.0% | |
| Nov 13, 2018 | ARDX Ardelyx, Inc. | President &CEO | Sell | 6,539 | $2.84 | $18,570.76 | -2.2% | |
| Apr 16, 2018 | FOLD Amicus Therapeutics, Inc. | Director | Sale+OE | 5,000 | $14.41 | $72,057.50 | -46.2% |